Viewing Study NCT01267812


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-26 @ 10:17 PM
Study NCT ID: NCT01267812
Status: COMPLETED
Last Update Posted: 2023-07-27
First Post: 2010-12-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
Sponsor: City of Hope Medical Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-10-03
Start Date Type: ACTUAL
Primary Completion Date: 2020-11-02
Primary Completion Date Type: ACTUAL
Completion Date: 2020-11-02
Completion Date Type: ACTUAL
First Submit Date: 2010-12-27
First Submit QC Date: None
Study First Post Date: 2010-12-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-01-12
Results First Submit QC Date: None
Results First Post Date: 2022-02-04
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-24
Last Update Post Date: 2023-07-27
Last Update Post Date Type: ACTUAL